The short version
Only one company currently supplies this market — there is no backup if it stumbles.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Uptravi
Selexipag · SELEXIPAG 1800 ug/10mL · Injection, Powder, For Solution · Intravenous · Actelion Pharmaceuticals US, Inc.
NDC 66215-0718-01 · 1 VIAL, SINGLE-DOSE in 1 CARTON / 10 mL in 1 VIAL, SINGLE-DOSE · NDA · View full market →
One drug, every price
The same NDC has different prices depending on who is paying. Units differ between rungs — compare within a rung over time, not rung against rung, unless the units match.
ⓘ How this was built
Data sources
- CMS NADAC (pharmacy acquisition, weekly)
- CMS Part B ASP quarterly payment limits
- CMS Maximum Fair Prices (IRA negotiated, NDC-level)
- Medicare Part D Spending by Drug (data.cms.gov, name-matched)
- VA FSS / Big4 federal contract prices (va.gov, twice monthly)
- ACA Federal Upper Limits + weighted AMP (data.medicaid.gov, monthly)
- California SB-17 WAC filings (list price, per package)
Method
Each rung is the newest figure for this NDC from one federal price system, shown with its own unit. Part D is matched by drug name because CMS publishes no NDCs there; it is gross spending, before confidential rebates.
Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.
- Part D plans paid (avg)$354.19per dosage unitgross, before rebates — matched by drug name · 2024
- Federal ceiling (Big4)$292.39per unitActelion Pharmaceuticals, U.S. Inc. · Jan 1, 2026
Medicare Part D
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Estimated fill cost
WAC per package, as filed
$397.06
Reported to Texas DSHS · 2026 annual filing · Johnson & Johnson Health Care Systems Inc
Manufacturer list price as filed — not what pharmacies actually pay after discounts.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
Where it's made
- Almac Pharma Services LimitedUnited Kingdomanalysis
- Almac Sciences LimitedUnited Kingdomanalysis · api manufacture
- analysis
- Eurofins Amatsigroup SasFrancemanufacture
- Konapharma AGSwitzerlandmanufacture
- Solvias FranceFranceanalysis
- Wickham Micro LimitedUnited Kingdomanalysis
Establishments this product's FDA label declares, located via FDA registration data. How we built this →
Is this a "specialty" drug?
There's no legal definition — it meets 2 of 6 public criteria. Why that matters →
- Part D specialty tier
- Costs ≥ $950/fill · avg $23,071.72 per prescription
- Biologic (BLA)
- Injectable / infused
- Orphan-drug exclusivity
- REMS program
Regulatory
- Application
- NDA214275
- TE code
- —
- Approval date
- Jul 29, 2021
- Patents / exclusivity
- 8 patents, 0 exclusivities
| Type | Number / code | Expires |
|---|---|---|
| patent | 8791122*PED | Feb 1, 2031 |
| patent | 9284280*PED | Dec 25, 2030 |
| patent | 8791122 | Aug 1, 2030 |
| patent | 9284280 | Jun 25, 2030 |
| patent | 9173881*PED | Feb 12, 2030 |
| patent | 9173881 | Aug 12, 2029 |
| patent | 7205302*PED | Apr 30, 2027 |
| patent | 7205302 | Oct 31, 2026 |
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of Selexipag (Injection, Powder, For Solution)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Actelion Pharmaceuticals US, Inc. | SELEXIPAG 1800 ug/10mL | Jul 15, 2026 | Sep 2, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Uptravi — NDC 66215-0718-01," retrieved September 3, 2026, https://drugdashboards.com/drug/66215071801.
Free to cite with attribution — see how the data is put together.